Efficacy and Safety of Linagliptin in 2681 Asian Patients Stratified by Age, Obesity, and Renal Function: A Pooled Analysis of Randomized Clinical Trials

INTRODUCTION: Asian patients with type 2 diabetes (T2D) are younger, leaner, and more likely to develop renal dysfunction than White populations. In this multiethnic analysis of data from phase 3 trials, we investigated the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in A...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Guang, Bandgar, Tushar, Hehnke, Uwe, Lee, Jisoo, Chan, Juliana C. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599450/
https://www.ncbi.nlm.nih.gov/pubmed/28819835
http://dx.doi.org/10.1007/s12325-017-0595-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599450/
https://www.ncbi.nlm.nih.gov/pubmed/28819835
http://dx.doi.org/10.1007/s12325-017-0595-7

Ejemplares similares